bmy 40062 has been researched along with Bacterial Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouzard, D; Cesare, PD; Essiz, M; Fung-Tomc, J; Jacquet, JP; Kessler, RE; Kiechel, JR; Ledoussal, B; Remuzon, P | 1 |
| Desiderio, JV; Fung-Tomc, J; Kessler, RE; Tsai, YH; Warr, G | 1 |
2 other study(ies) available for bmy 40062 and Bacterial Disease
| Article | Year |
|---|---|
Fluoronaphthyridines and -quinolones as antibacterial agents. 3. Synthesis and structure-activity relationships of new 1-(1,1-dimethyl-2-fluoroethyl), 1-[1-methyl-1-(fluoromethyl)-2-fluoroethyl], and 1-[1,1-(difluoromethyl)-2-fluoroethyl] substituted deri
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Dogs; Indicators and Reagents; Mice; Microbial Sensitivity Tests; Molecular Structure; Naphthyridines; Structure-Activity Relationship | 1991 |
In vitro and in vivo antibacterial activities of BMY 40062, a new fluoronaphthyridone.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Macrophages; Mice; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin | 1989 |